TY - JOUR T1 - Use of Integra dermal substitute to prevent implantable device extrusion in an Olympic athlete JF - BMJ Case Reports DO - 10.1136/bcr-2018-226181 VL - 2018 SP - bcr-2018-226181 AU - Felicity Page AU - Krupali Patel AU - Wayne Jaffe Y1 - 2018/11/08 UR - http://casereports.bmj.com/content/2018/bcr-2018-226181.abstract N2 - We present a challenging case of imminent metallic implant extrusion in a Paralympic athlete managed with a single-stage procedure using ‘Integra’ dermal substitute. The patient had hereditary spastic paraparesis, for which a baclofen pump delivering intrathecal medication was vital in the management of his condition. The device had been most recently implanted into the thigh after previous complications. Integra provided robust soft-tissue coverage over the implanted baclofen pump in the thigh. Different operative management strategies were considered but the use of Integra was felt to offer the least morbidity and a quick recovery. The patient was able to successfully compete in a Paralympic canoeing qualifying event the week following surgery and achieve medal success. To the authors’ knowledge, this is first case in which Integra has been used in such circumstances. ER -